Camrelizumab
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| H101 Combined With Camrelizumab for Recurrent Cervical Cancer (NCT05234905) | Zhejiang Cancer Hospital | 2022-03-01 |
| Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses (NCT05114707) | Sun Yat-sen University | 2021-04-16 |
Track Camrelizumab automatically
Every clearance here is in the API, with alerts when new ones post.